UPC
$2.63+0.03 (+1.33%)
Market OpenAs of Mar 17, 2:50 PM UTC
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.63
Potential Upside
5%
Whystock Fair Value$2.76
Price
UndervaluedFair ValueOvervalued
Fundamentals
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.48M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.57
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-7.23%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
3.55
Recent News
Universe Pharmaceuticals Reports First Half 2025 Earnings
Universe Pharmaceuticals ( NASDAQ:UPC ) First Half 2025 Results Key Financial Results Revenue: US$9.15m (down 29% from...
Universe Pharmaceuticals Reports Full Year 2024 Earnings
Universe Pharmaceuticals ( NASDAQ:UPC ) Full Year 2024 Results Key Financial Results Revenue: US$23.0m (down 29% from...